Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study
Institute of Cancer Research · National Cancer Registration Service · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
501
total citations
- FWCI
- 33.66
- Percentile
- 100%
- References
- 21
Citations per year
Authors
23Topics & keywords
Topics
Keywords
- Medicine
- Pandemic
- Referral
- Coronavirus disease 2019 (COVID-19)
- Cancer
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- 2019-20 coronavirus outbreak
- Overall survival
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- BSBristol-Myers Squibb
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- MFMovember FoundationAward: C1298/A8362
- BCBreast Cancer Now
- WTWellcome TrustAward: FC001169
- FCFrancis Crick InstituteAward: FC001169
- LLLes Laboratories Pierre Fabre
- CFCancer Focus Northern Ireland
- URUK Research and Innovation
- IIncyte
- CRCancer Research UKAwards: C1298/A8362, C57955/A24390, A18180, C61296/A27223, C18081, A23385, C8640/A23385, C18081/A18180, C8640, FC001169
- NINational Institute for Health and Care ResearchAward: C8640/A23385
- IOInstitute of Cancer Research
- EEisai
- IIpsen
- EPEUSA Pharma
- PPharmacyclics
- MRMedical Research CouncilAwards: MR/T02481X/1, FC001169